Madrigal Pharmaceuticals (MDGL)
(Delayed Data from NSDQ)
$236.16 USD
+10.67 (4.73%)
Updated May 31, 2024 04:00 PM ET
After-Market: $236.50 +0.34 (0.14%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-7.55 | 0.00% |
Earnings Summary
For their last quarter, Madrigal Pharmaceuticals (MDGL) reported earnings of -$7.38 per share, missing the Zacks Consensus Estimate of -$6.06 per share. This reflects a negative earnings surprise of 21.78%. Look out for MDGL's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$7.55 per share, reflecting a year-over-year decrease of 60.98%.
Earnings History
Price & Consensus
Zacks News for MDGL
2 Top Biotech Buyout Candidates
MDGL: What are Zacks experts saying now?
Zacks Private Portfolio Services